AngioDynamics Q4 Adjusted EPS $0.02, Inline, Sales $91.07M Beat $90.73M Estimate
Portfolio Pulse from Benzinga Newsdesk
AngioDynamics (NASDAQ:ANGO) reported Q4 earnings of $0.02 per share, meeting analyst consensus. This is a 100% increase from the same period last year. The company also reported quarterly sales of $91.07 million, beating the analyst consensus estimate of $90.73 million by 0.38%, a 4.69% increase from last year.
July 12, 2023 | 11:02 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
AngioDynamics reported Q4 earnings in line with analyst expectations and a significant YoY increase. Sales also beat estimates and showed a YoY increase.
AngioDynamics reported strong Q4 results with earnings meeting analyst expectations and showing a 100% increase YoY. Sales also exceeded estimates and increased by 4.69% YoY. This positive financial performance could lead to a short-term increase in the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100